Simple access to private funding for therapeutics research.

Molecule's platform and scalable framework for biotech DAOs connects academics and biotech companies with quick and easy funding, while enabling patient, researcher, and investor communities to directly govern and own research-related IP.

Molecule is a digital interface matching supply and demand for biotech and pharma assets. Most of those assets currently live inside universities, small biotech companies, and, increasingly, AI drug discovery companies. Molecule crawls and lists research projects and enriches the data over time (this is increasingly done by researchers themselves who "claim" and develop their profiles). Interested investors can search pre-vetted projects depending on their therapeutic area, clinical stage and type of project.